Trending Articles

article thumbnail

A 2,100% Markup: My Battle with a Vastly Overpriced Knee Brace — and U.S. Healthcare

MedCity News

I asked if I could purchase the brace myself and bring it to the surgery. The answer was an unequivocal no: the health insurers contracted rate required me to purchase the brace from the hospital as part of the procedure. The post A 2,100% Markup: My Battle with a Vastly Overpriced Knee Brace and U.S. Healthcare appeared first on MedCity News.

article thumbnail

How to Succeed as a Clinical Specialist in Medical Sales With Gina Torres

Evolve Your Success

Breaking Into Medical Sales: Gina Torres’s Journey from Nurse to Industry Expert In this inspiring episode, Gina Torres, a seasoned peripheral vascular representative, shares her incredible transition from a peripheral vascular nurse to a top medical device sales expert at Shockwave. Discover how she leveraged her clinical background to drive innovation and improve patient outcomes, particularly in preventing amputations for those with peripheral arterial disease.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What’s driving pharma’s layoffs in 2025

PharmaVoice

Familiar foes in the industry have claimed a slew of jobs in recent months.

294
294
article thumbnail

Bristol Myers Squibb to acquire 2seventy bio

European Pharmaceutical Review

Bristol Myers Squibb has agreed a merger with 2seventy bio in a deal worth approximately $286 million. A year ago, 2seventy decided to exclusively focus on unlocking the value of Abecma, with the goal of delivering more time for people living with multiple myeloma and maximizing value for all stakeholders, stated Chip Baird, Chief Executive Officer, 2seventy bio.

article thumbnail

The Intersection of AI and Sales: Personalization Without Compromise

Speaker: Jesse Hunter and Brynn Chadwick

Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.

article thumbnail

Overcoming Life’s Obstacles: The Power of Resilience and Grit

Scott Burrows

Life is unpredictable. Its full of challenges that can hit when we least expect them. For me, one of those challenges came at the peak of my athletic career. At 19 years old, I was living my dream as a star wide receiver for Florida State University and a black-belt kickboxer. My last fight had even been televised on ESPN. But in a single, fateful moment, everything changed.

More Trending

article thumbnail

Are you moving to more of an omnichannel marketing approach?

Pharma Marketing Network

Introduction In todays competitive pharmaceutical landscape, marketing strategies must evolve to meet changing customer expectations. Are you still relying on traditional marketing tactics, or have you embraced a more dynamic, omnichannel marketing approach? With healthcare providers (HCPs) and patients engaging across multiple digital and offline touchpoints, pharma brands that fail to adapt risk losing valuable market share.

article thumbnail

As tariffs loom over pharma manufacturing, a reshoring effort is underway — but not without challenges

PharmaVoice

Experts say cost and other barriers present challenges to returning to U.S. shores.

article thumbnail

How HealthTrackRx Revolutionized PCR Testing by Delivering Next-Morning Results at Scale

Healthcare Success

Do you remember choosing between two types of COVID tests? PCR tests were highly accurate but took several days to get results. Meanwhile, antigen-based rapid tests offered results within minutes, but were far less accurate. In this week's episode, Stewart Gandolf speaks with Martin Price , CEO of HealthTrackRx , to explore how an innovative business model, leading-edge sales strategies, and game-changing partnerships has enabled HealthTrackRx to offer and scale next-morning PCR results nationwi

article thumbnail

“Uncertainty Fatigue”: The Invisible Force Draining Your Team’s Engagement and Productivity

ALULA

Explore the concept of "uncertainty fatigue" and its profound impact on employees dealing with rapid workplace transformations, global events, and economic volatility. Understand the symptoms and consequences of this growing challenge and discover six practical strategies that leaders can implement to foster resilience, reduce stress, and enhance overall well-being in the workplace.

52
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity

MedCity News

Roche will share in developing and commercializing petrelintide, a clinical-stage Zealand Pharma drug that activates the amylin receptor to spark weight loss. This agreement represents the highest total financial consideration in the obesity field to date. The post Roche Puts Up $1.65B to Partner With Zealand on Future Foundational Therapy for Obesity appeared first on MedCity News.

Pharma 232
article thumbnail

Strategies For A Pharma Ad Ban on TV

Pharma Marketing Network

Table of Contents The Impact of a Pharma Ad Ban on TV Digital Marketing as a Primary Alternative Leveraging Data-Driven Advertising Strategies Strengthening Direct-to-Consumer (DTC) Engagement The Impact of a Pharma Ad Ban on TV The potential for a pharma ad ban on TV has sparked intense discussions among marketing executives. If regulations change, pharmaceutical brands must rethink their advertising strategies to maintain visibility and patient engagement.

Pharma 59
article thumbnail

Lawmakers tease out pharma’s influence over RFK Jr. through probe into Mar-a-Lago meetings

PharmaVoice

HHS head Robert F. Kennedy Jr. has long been an opponent of pharma influence in government. U.S. lawmakers are asking whether unofficial Mar-a-Lago meetings point to a change of heart.

article thumbnail

MSD bolsters US manufacturing capacity with $1b investment

European Pharmaceutical Review

MSD has announced it has opened a new $1 billion vaccine manufacturing facility at its site in Durham, North Carolina, US. “Expanding our state-of-the-art manufacturing facility in Durham marks a significant milestone in our efforts to strengthen our production and manufacturing capabilities in the US,” commented Sanat Chattopadhyay, Executive Vice President and President, Merck Manufacturing Division.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Navigating Pharma Sales Challenges: Tips to Boost Your Sales Performance (Use of AI and Social Media for Effective brand promotion)

Pharmaceutical Representative Training

The Evolution of Pharma Sales: Combining AI and Social Media to Promote Brands Pharmaceutical businesses now have access to a whole new level of insights due to social media. Real-world intelligence is evident in the discussions taking place on social media. Social medias position in pharmaceutical research is further cemented by peoples growing usage of it.

Media 52
article thumbnail

Fluency Isn’t Intelligence in Healthcare

MedCity News

The current wave of generative AI has captured public imagination, but we must temper our expectations. While these models demonstrate impressive capabilities in processing vast amounts of medical literature and generating coherent text, they’re far from perfect. The post Fluency Isnt Intelligence in Healthcare appeared first on MedCity News.

article thumbnail

Marketing Strategies for Pharma Brands: Driving HCP Engagement

Pharma Marketing Network

Table of Contents Understanding the Importance of HCP Engagement in Pharma Marketing Key Marketing Strategies for Pharma Brands to Reach HCPs Optimizing Digital and Paid Media Strategies for Pharma Marketing Measuring Success: Tracking HCP Engagement and ROI Understanding the Importance of HCP Engagement in Pharma Marketing Engaging healthcare professionals (HCPs) effectively is a top priority for pharmaceutical brands.

article thumbnail

The first new type of drug for Tourette syndrome in over 50 years is close to the FDA’s doorstep

PharmaVoice

Emalex Biosciences is full steam ahead with a targeted 2026 approval and launch for its novel drug.

165
165
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

AstraZeneca and Ionis win EU approval for ATTR polyneuropathy

Pharmaceutical Technology

AstraZeneca and Ionis are intensifying their competition with Alnylam by securing an EU approval for Wainzua.

article thumbnail

Nuvera launches expanded data-driven solutions and grows leadership team to elevate the patient and HCP experience

PM360

Cedar Knolls, NJ March 12th, 2025 Nuvera, part of Inizio Engage, has launched an expanded set of data led, insights-driven client solutions and strengthened its dynamic leadership team under the guidance of Derek Cothran, all showcased in its newly launched website. Nuvera is a leading consulting firm dedicated to designing, building, and measuring patient and HCP treatment experiences for rare diseases, specialty medicines, and cell and gene therapeutics.

article thumbnail

Better Science, Better Medicine: How Clinical Research Advances Women’s Health

MedCity News

Modern trial designs, digital solutions and a deeper understanding of patient realities are helping to open research to more people, including women and others who have historically been underrepresented. The post Better Science, Better Medicine: How Clinical Research Advances Women’s Health appeared first on MedCity News.

Medicine 157
article thumbnail

Do Paid Social Media Campaigns work?

Pharma Marketing Network

Table of Contents Understanding Paid Social Media Campaigns in Pharma Marketing Key Benefits of Paid Social Media Advertising for Pharma Brands Best Practices for Optimizing Paid Social Media Campaigns Measuring Success: How to Track ROI and Engagement Understanding Paid Social Media Campaigns in Pharma Marketing Pharmaceutical marketing has evolved significantly with the rise of paid social media campaigns , enabling brands to reach healthcare professionals (HCPs), patients, and caregivers in w

Media 52
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Drug developers ‘haven’t even scratched the surface’ of what radiopharma can do

PharmaVoice

Even with Big Pharmas pouring billions into the space, the potential of radiopharmaceuticals remains largely untapped.

Pharma 147
article thumbnail

Careology and Entia join forces to transform cancer care

PharmaTimes

Collaboration brings remote care to cancer patients

article thumbnail

Concern as measles cases doubled in Europe last year

pharmaphorum

A sharp rise in measles cases in 2024 in Europe has led to widespread calls for a concerted effort to ramp up vaccination rates

101
101
article thumbnail

Bristol Myers Squibb Buys Out Cancer Cell Therapy Partner 2seventy Bio in $286M Deal

MedCity News

Multiple myeloma cell therapy Abecma is the lone remaining asset of 2seventy Bio, which spun out from Bluebird Bio in 2021. 2seventy and Bristol Myers Squibb currently share in U.S. commercialization of Abecma. The post Bristol Myers Squibb Buys Out Cancer Cell Therapy Partner 2seventy Bio in $286M Deal appeared first on MedCity News.

Biopharma 175
article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

How to integrate AI in Pharma Marketing

Pharma Marketing Network

Table of Contents Understanding the Role of AI in Pharma Marketing Key Benefits of AI Integration in Pharma Marketing AI-Powered Strategies for Pharma Marketers Overcoming Challenges in AI Adoption Understanding the Role of AI in Pharma Marketing The pharmaceutical industry is undergoing a digital transformation, and AI in pharma marketing is at the forefront of this evolution.

article thumbnail

Takeda’s $770M deal deepens Big Pharma’s omics push

PharmaVoice

The pharma giant announced a new partnership with BridGene Biosciences that will use its IMTAC platform for drug discovery.

Pharma 147
article thumbnail

MeiraGTx and Hologen launch AI-backed gene therapy venture

Pharmaceutical Technology

The venture aims to advance MeiraGTxs Parkinsons gene therapy through Phase III trials with up to $430m in funding from Hologen.

101
101